Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nicolaides

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|May 13, 2010
Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug deliveryDennis J Yoon, Byron H Kwan, Felix C Chao, et al.
Nanomaterials (Basel, Switzerland)|December 20, 2018
Evaluation of Three Morphologically Distinct Virus-Like Particles as Nanocarriers for Convection-Enhanced Drug Delivery to GlioblastomaJoel A Finbloom, Ioana L Aanei, Jenna M Bernard, et al.
Human Molecular Genetics|May 16, 1998
Non-disjunction of chromosome 18M Bugge, A Collins, M B Petersen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 20, 2004
The longer term outcome of children born to mothers with epilepsyN Adab, U Kini, J Vinten, et al.
Cytogenetic and Genome Research|April 11, 2012
Tetrasomy 9p mosaicism associated with a normal phenotype in two casesI Papoulidis, M Kontodiou, M Tzimina, et al.
Oncotarget|October 8, 2016
Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma modelStefan Grossauer, Katharina Koeck, Nicole E Murphy, et al.
Journal of Neuro-Oncology|September 20, 2015
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Journal of Neuro-Oncology|January 20, 2016
Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Cell Reports|August 22, 2019
Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma AggressivenessHanna Sabelström, Rebecca Petri, Ksenya Shchors, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Targeted therapy for BRAFV600E malignant astrocytomaTheodore P Nicolaides, Huifang Li, David A Solomon, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|May 13, 2010
Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug deliveryDennis J Yoon, Byron H Kwan, Felix C Chao, et al.
Nanomaterials (Basel, Switzerland)|December 20, 2018
Evaluation of Three Morphologically Distinct Virus-Like Particles as Nanocarriers for Convection-Enhanced Drug Delivery to GlioblastomaJoel A Finbloom, Ioana L Aanei, Jenna M Bernard, et al.
Human Molecular Genetics|May 16, 1998
Non-disjunction of chromosome 18M Bugge, A Collins, M B Petersen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 20, 2004
The longer term outcome of children born to mothers with epilepsyN Adab, U Kini, J Vinten, et al.
Cytogenetic and Genome Research|April 11, 2012
Tetrasomy 9p mosaicism associated with a normal phenotype in two casesI Papoulidis, M Kontodiou, M Tzimina, et al.
Oncotarget|October 8, 2016
Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma modelStefan Grossauer, Katharina Koeck, Nicole E Murphy, et al.
Journal of Neuro-Oncology|September 20, 2015
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Journal of Neuro-Oncology|January 20, 2016
Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Cell Reports|August 22, 2019
Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma AggressivenessHanna Sabelström, Rebecca Petri, Ksenya Shchors, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Targeted therapy for BRAFV600E malignant astrocytomaTheodore P Nicolaides, Huifang Li, David A Solomon, et al.
Pageof 5